Literature DB >> 27152018

The Opioid Drug Epidemic and Sickle Cell Disease: Guilt by Association.

Nadia S Ruta1, Samir K Ballas1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27152018     DOI： 10.1093/pm/pnw074

Source DB:  PubMed          Journal:  Pain Med        ISSN： 1526-2375            Impact factor:   3.750


× No keyword cloud information.
  21 in total

1.  American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.

Authors:  Amanda M Brandow; C Patrick Carroll; Susan Creary; Ronisha Edwards-Elliott; Jeffrey Glassberg; Robert W Hurley; Abdullah Kutlar; Mohamed Seisa; Jennifer Stinson; John J Strouse; Fouza Yusuf; William Zempsky; Eddy Lang
Journal:  Blood Adv       Date:  2020-06-23

Review 2.  Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease.

Authors:  Junaid Ansari; Youmna E Moufarrej; Rafal Pawlinski; Felicity N E Gavins
Journal:  Expert Rev Hematol       Date:  2017-12-05       Impact factor: 2.929

3.  Daily Associations between Child and Parent Psychological Factors and Home Opioid Use in Youth with Sickle Cell Disease.

Authors:  Amanda L Stone; Zaria Williams; Melissa McNaull; Anna C Wilson; Cynthia W Karlson
Journal:  Ann Behav Med       Date:  2020-01-01

4.  Gabapentin alleviates chronic spontaneous pain and acute hypoxia-related pain in a mouse model of sickle cell disease.

Authors:  Katelyn E Sadler; Sarah N Langer; Anthony D Menzel; Francie Moehring; Ashley N Erb; Amanda M Brandow; Cheryl L Stucky
Journal:  Br J Haematol       Date:  2019-06-27       Impact factor: 6.998

5.  A Preliminary Investigation of the Underlying Mechanism Associating Daily Sleep Continuity Disturbance and Prescription Opioid Use Among Individuals With Sickle Cell Disease.

Authors:  Chung Jung Mun; Patrick H Finan; Michael T Smith; C Patrick Carroll; Joshua M Smyth; Sophie M Lanzkron; Jennifer A Haythornthwaite; Claudia M Campbell
Journal:  Ann Behav Med       Date:  2021-06-02

6.  Medical marijuana certification for patients with sickle cell disease: a report of a single center experience.

Authors:  Susanna A Curtis; Dana Lew; Jonathan Spodick; Jeanne E Hendrickson; Caterina P Minniti; John D Roberts
Journal:  Blood Adv       Date:  2020-08-25

7.  Pediatric residents' perceived barriers to opioid use in sickle cell disease pain management.

Authors:  Amber Fearon; Anne Marsh; Jennifer Kim; Marsha Treadwell
Journal:  Pediatr Blood Cancer       Date:  2018-11-01       Impact factor: 3.167

8.  Do chronic pain and comorbidities affect brain function in sickle cell patients? A systematic review of neuroimaging and treatment approaches.

Authors:  Joyce T Da Silva; Janelle E Letzen; Jennifer A Haythornthwaite; Patrick H Finan; Claudia M Campbell; David A Seminowicz
Journal:  Pain       Date:  2019-09       Impact factor: 7.926

9.  Oral morphine protocol evaluation for the treatment of vaso-occlusive crisis in paediatric sickle cell patients.

Authors:  Hugo Paquin; Evelyne D Trottier; Nancy Robitaille; Yves Pastore; Marie-Joelle Dore Bergeron; Benoit Bailey
Journal:  Paediatr Child Health       Date:  2018-05-31       Impact factor: 2.253

10.  Psychosocial and Clinical Risk Factors Associated with Substance Use in Observational Cohort of Patients with Sickle Cell Disease.

Authors:  J Deanna Wilson; Sophie Lanzkron; Lydia H Pecker; Shawn M Bediako; Dingfen Han; Mary Catherine Beach
Journal:  Subst Use Misuse       Date:  2020-08-07       Impact factor: 2.164
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.